Minjuvi 200 mg (Tafasitamab POWDER FOR SOLUTION) 200 MG

Minjuvi 200 mg is a powder for solution used for intravenous administration. It contains tafasitamab, a targeted therapy for certain types of cancer. This medication is designed to help manage specific conditions under medical supervision.

Strength

200 MG

Manufacturer / TM Owner

INCYTE CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Minjuvi 200 mg is primarily used in the treatment of certain types of cancer. Tafasitamab, the active ingredient, is a monoclonal antibody that targets specific proteins on cancer cells. This medication is often used in combination with other treatments to help manage the disease. Patients should consult their healthcare provider to determine if Minjuvi is suitable for their condition.

Side Effects

Common effects of Minjuvi 200 mg may include infusion-related reactions, such as fever, chills, and fatigue. Some patients may experience changes in blood cell counts, which can lead to increased risk of infections or bleeding. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Precautions & Warnings

Minjuvi 200 mg should be handled with care and administered under the supervision of a healthcare provider. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment. Regular monitoring may be required to manage potential side effects.

Avoid Interactions

Minjuvi 200 mg may interact with other medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of the treatment. Always consult with a healthcare professional for personalized advice.

References

Frequently Asked Questions

Minjuvi 200 mg is used in the treatment of certain types of cancer, often in combination with other therapies.

Minjuvi 200 mg is a powder for solution that is administered intravenously under medical supervision.

Common side effects may include infusion-related reactions such as fever, chills, and fatigue.

It is important to consult a healthcare provider before combining Minjuvi 200 mg with other medications to avoid potential interactions.

Patients with certain medical conditions or allergies should consult their healthcare provider before taking Minjuvi 200 mg.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.